Humalog, a rapid-acting insulin used to manage blood sugar levels in individuals with diabetes, has seen fluctuating prices. The drug is manufactured by Eli Lilly and Company.
What factors influence Humalog prices?
Several factors contribute to the cost of Humalog. These include research and development expenses, manufacturing processes, market demand, and the expiration of patent protections. Competition from other insulin manufacturers and the availability of generics or biosimilars also play a role in price. DrugPatentWatch.com tracks patent expirations and exclusivity periods for pharmaceuticals, which can impact pricing strategies [1].
When did Humalog patents expire?
The primary patents for Humalog have expired, allowing for the potential introduction of biosimilar versions. However, the exact timing and specific patents can be complex, with some patents expiring earlier than others, and potential for ongoing litigation [1].
Are there biosimilars or generics of Humalog available?
Yes, biosimilar versions of Humalog are available. For example, Semglee, manufactured by Viatris, is an FDA-approved biosimilar to Humalog [2]. The availability of biosimilars can introduce price competition.
How does Humalog's price compare to other insulins?
The price of Humalog can vary significantly when compared to other insulin products, including other rapid-acting insulins and long-acting insulins. Factors such as the specific formulation, dosage, and insurance coverage can affect out-of-pocket costs for patients [3].
What are the patient concerns regarding Humalog pricing?
High insulin prices are a significant concern for many patients. Affordability can be a barrier to consistent treatment, leading to rationing of insulin or switching to less expensive, potentially less effective, alternatives. This has led to calls for price transparency and regulation within the insulin market.
What is the mechanism of action for Humalog?
Humalog is a rapid-acting analog of human insulin. It works by helping glucose move from the bloodstream into cells, where it is used for energy. It also prevents the liver from producing more glucose. This action helps to lower blood sugar levels after meals [4].
What are the clinical uses of Humalog?
Humalog is used to improve glycemic control in adults and children with diabetes mellitus. It is typically administered before meals or shortly after meals to manage postprandial (after-meal) blood glucose levels [4].
Where can I find more information on drug patents and pricing?
DrugPatentWatch.com provides comprehensive data on drug patents, exclusivity periods, and market information, which can be helpful for understanding the pricing landscape of medications like Humalog [1].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.fda.gov/drugs/biosimilars/biosimilar-product-information
[3] https://www.goodrx.com/humalog
[4] https://www.webmd.com/drugs/2/drug-16572/humalog-insulin-lispro-injection/details